In a bold move that’s got everyone talking, Texas has decided to take on Johnson & Johnson and Kenvue, claiming they’ve been hiding some serious risks about Tylenol—yes, the go-to painkiller for pregnant women. The Texas Attorney General is throwing down the gauntlet, alleging that these companies suppressed evidence linking Tylenol, a seemingly harmless pain reliever, to autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD).
Texas is challenging Johnson & Johnson and Kenvue over hidden risks of Tylenol linked to autism and ADHD.
Seriously? The lawsuit claims they marketed Tylenol as the only safe option for pregnant women while conveniently ignoring the red flags.
And what’s the twist? Kenvue was spun off by J&J just last year, seemingly to dodge future lawsuits like a pro. Talk about a corporate shuffle! This legal saga gained traction after President Trump made waves with his comments about Tylenol’s supposed risks. It’s like a soap opera, but with a lot more legal jargon.
The scientific evidence is a mixed bag. Sure, the complaint pulls in at least 26 studies suggesting that prenatal acetaminophen exposure could spell trouble, but hold on—other peer-reviewed studies, including a massive Swedish cohort study, found no significant link when sibling controls were considered. The FDA announced it was seeking to include a warning on acetaminophen labels about possible connection to neurodevelopmental disorders. [In fact, professional associations have found no proven link between acetaminophen use in pregnancy and neurodevelopmental disorders, emphasizing the need for scientific consensus.]
So, which is it? A February 2025 review even concluded that prenatal acetaminophen is “unlikely to confer a clinically important increased risk” for autism. The scientific community is divided, and that’s putting it lightly.
Regulatory bodies like the FDA have acknowledged a “possible association” but stopped short of blaming Tylenol outright. And in December 2023, Judge Denise Cote dismissed federal claims, citing shaky methodology and a lack of consensus.
Despite this, hundreds of state-level lawsuits are marching forward, and the potential financial fallout? We’re talking tens of billions of dollars.
Now, with about 65% of pregnant women using acetaminophen, any change in guidance could rock their world. This lawsuit is a loud wake-up call, shining a spotlight on decades of alleged deception.
Buckle up; this is just getting started.
